RedFlag Research Initiative Tracks Telehealth’s Controlled-Substance Shift

Field notes

The initiative structures its work around four questions concerning prevalence, provider and business models, administrative-data signals, and changes in patient access. The page cites a rise in telehealth use for opioid use disorder treatment from 27.5% of facilities in 2019 to about 76%, and identifies December 31, 2026 as the stated end date for temporary federal prescribing rules. It says study definitions, cohorts, and analytic code will accompany each release.